A De Novo Mutation in COL1A1 in a Holstein Calf with Osteogenesis Imperfecta Type II

被引:2
|
作者
Jacinto, Joana G. P. [1 ,2 ]
Haefliger, Irene M. [2 ]
McEvoy, Fintan J. [3 ]
Droegemueller, Cord [2 ]
Agerholm, Jorgen S. [3 ]
机构
[1] Univ Bologna, Dept Vet Med Sci, I-40064 Ozzano Dell Emilia, Italy
[2] Univ Bern, Vetsuisse Fac, Inst Genet, CH-3012 Bern, Switzerland
[3] Univ Copenhagen, Dept Vet Clin Sci, Dyrlaegevej 16, DK-1870 Copenhagen, Denmark
来源
ANIMALS | 2021年 / 11卷 / 02期
基金
瑞士国家科学基金会;
关键词
cattle; Bos taurus; collagenopathy; skeletal disorder; bone disease; rare diseases; precision medicine; whole-genome sequencing;
D O I
10.3390/ani11020561
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary Skeletal connective tissue disorders represent a heterogeneous group of inherited disorders mostly monogenically inherited. Heritable connective tissue disorders such as osteogenesis imperfecta (OI) belong to this group. Herein, an affected calf showing congenital bone lesions such as intrauterine fractures, abnormally shaped long bones and localized arthrogryposis resembling OI type II is reported. Whole-genome sequencing (WGS) identified a most likely disease-causing mutation in the COL1A1 gene. The COL1A1 gene is known to be associated with dominant inherited OI type II forms in humans and sporadically in dogs and cattle, but so far, a variant in the fibrillar collagen NC1 domain has not been shown to cause a similar phenotype in domestic animals. We assume that the herein identified most-likely causative variant occurred either within the parental germlines or post-zygotically in the developing embryo. Rare lethal disorders such as OI in livestock are usually not diagnosed to the molecular level, mainly because of the lack of resources and diagnostic tools. WGS-based precision diagnostics allows understanding rare disorders and supports the value of surveillance of cattle breeding populations for harmful genetic disorders. Osteogenesis imperfecta (OI) type II is a genetic connective tissue disorder characterized by bone fragility, severe skeletal deformities and shortened limbs. OI usually causes perinatal death of affected individuals. OI type II diagnosis in humans is established by the identification of heterozygous mutations in genes coding for collagens. The purpose of this study was to characterize the pathological phenotype of an OI type II-affected neonatal Holstein calf and to identify the causative genetic variant by whole-genome sequencing (WGS). The calf had acute as well as intrauterine fractures, abnormally shaped long bones and localized arthrogryposis. Genetic analysis revealed a private heterozygous missense variant in COL1A1 (c.3917T>A) located in the fibrillar collagen NC1 domain (p.Val1306Glu) that most likely occurred de novo. This confirmed the diagnosis of OI type II and represents the first report of a pathogenic variant in the fibrillar collagen NC domain of COL1A1 associated to OI type II in domestic animals. Furthermore, this study highlights the utility of WGS-based precise diagnostics for understanding congenital disorders in cattle and the need for continued surveillance for rare lethal genetic disorders in cattle.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 50 条
  • [1] A recurrent de novo missense mutation in COL1A1 causes osteogenesis imperfecta type II and preterm delivery in Normande cattle
    Corbeau, Julien
    Grohs, Cecile
    Jourdain, Jeanlin
    Boussaha, Mekki
    Besnard, Florian
    Barbat, Anne
    Plassard, Vincent
    Riviere, Julie
    Hamelin, Christophe
    Mortier, Jeremy
    Boichard, Didier
    Guatteo, Raphael
    Capitan, Aurelien
    GENETICS SELECTION EVOLUTION, 2024, 56 (01)
  • [2] A novel de novo mutation in COL1A1 leading to osteogenesis imperfecta confirmed by zebrafish model
    Huang, Huan
    Liu, Jiamei
    Zhang, Guoying
    CLINICA CHIMICA ACTA, 2021, 517 : 133 - 138
  • [3] A novel de novo COL1A1 mutation in a Thai boy with osteogenesis imperfecta born to consanguineous parents
    Tongkobpetch, Siraprapa
    Limpaphayom, Noppachart
    Sangsin, Apiruk
    Porntaveetus, Thantrira
    Suphapeetiporn, Kanya
    Shotelersuk, Vorasuk
    GENETICS AND MOLECULAR BIOLOGY, 2017, 40 (04) : 763 - 767
  • [4] Osteogenesis imperfecta - New mutation in the Col1a1 gene
    Viana, R.
    Semenova, T.
    Pedroso, S.
    Cerqueira, R.
    Fernandes, R.
    Rendeiro, P.
    Tavares, P.
    Ferreira, J.
    Almeida, M.
    Santos, A.
    Rebordao, M.
    Hermida, M.
    PROCEEDINGS OF THE 8TH WORLD CONGRESS OF PERINATAL MEDICINE, 2007, : 799 - 802
  • [5] Prenatal diagnosis of type II osteogenesis imperfecta, describing a new mutation in the COL1A1 gene
    Aerts, M
    Van Holsbeke, C
    de Ravel, T
    Devlieger, R
    PRENATAL DIAGNOSIS, 2006, 26 (04) : 393 - 394
  • [6] A De novo Mutation in the COL1A1 Gene Leading to Severe Osteogenesis Imperfecta: Case Report and Review of the Literature
    Lu, Yurong
    Tian, Yijia
    Liu, Jinxiu
    Wang, Yifan
    Wang, Xietong
    AJP REPORTS, 2024, 14 (03): : e215 - e223
  • [7] Osteogenesis imperfecta type 1: A case presentation with a new mutation in gene COL1A1
    Siegert, T
    Klein, HG
    Marschall, C
    Schmidt, H
    KLINISCHE PADIATRIE, 2004, 216 (02): : 91 - 93
  • [8] COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta
    Benusiene, Egle
    Kucinskas, Vaidutis
    JOURNAL OF APPLIED GENETICS, 2003, 44 (01) : 95 - 102
  • [9] A novel COL1A1 mutation causing a variant of osteogenesis imperfecta
    McVey, Lindsey C.
    Mason, Avril
    Pollitt, Rebecca
    Ahmed, Syed Faisal
    Kinning, Esther
    CLINICAL DYSMORPHOLOGY, 2017, 26 (04) : 243 - 246
  • [10] Whole-exome sequencing identifies de novo mutation in the COL1A1 gene to underlie the severe osteogenesis imperfecta
    Katre Maasalu
    Tiit Nikopensius
    Sulev Kõks
    Margit Nõukas
    Mart Kals
    Ele Prans
    Lidiia Zhytnik
    Andres Metspalu
    Aare Märtson
    Human Genomics, 9